Inflammatory pathways in the pathogenesis of iatrogenic laryngotracheal stenosis: What do we know?

Ruth J. Davis, Alexander T. Hillel

Research output: Contribution to journalReview articlepeer-review

Abstract

Iatrogenic laryngotracheal stenosis (LTS) is pathologic airway narrowing due to scar formation following endotracheal intubation or tracheostomy. It is a chronic and recurrent disease that results in significant morbidity or even mortality. Current data suggests that inflammatory pathways play a significant role in mediating the deposition of collagen and extracellular matrix to generate this scar. In particular, the T-helper 2 cell and M2 macrophage axis appears to be activated in both animal models and patients with iatrogenic LTS. Interleukin-6 production in response to hypoxia has also been implicated. In this paper, we review the data supporting the roles of various inflammatory pathways in the pathogenesis of iatrogenic LTS, discuss potential therapeutic approaches targeting these mechanisms, and outline areas for future study.

Original languageEnglish (US)
Pages (from-to)2108-2116
Number of pages9
JournalTranslational Cancer Research
Volume9
Issue number3
DOIs
StatePublished - 2020

Keywords

  • Helper T-cells
  • Inflammation
  • Interleukin-4
  • Macrophages
  • Tracheal stenosis

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Inflammatory pathways in the pathogenesis of iatrogenic laryngotracheal stenosis: What do we know?'. Together they form a unique fingerprint.

Cite this